NCT03666143 2024-11-04A Phase 1b Study to Assess Sitravatinib in Combination With Tislelizumab in Participants With Advanced Solid TumorsBeiGenePhase 1 Completed216 enrolled 20 charts
NCT04887194 2024-05-08PK Study to Assess Drug-drug Interaction and QTc Between Sitravatinib and a Cocktail of SubstratesMirati Therapeutics Inc.Phase 1 Completed40 enrolled